Veronica Mullally Muoz Partner New York Veronica Mullally

  • Slides: 1
Download presentation
Veronica Mullally Muñoz Partner, New York Veronica Mullally Muñoz is a partner in the

Veronica Mullally Muñoz Partner, New York Veronica Mullally Muñoz is a partner in the Litigation and Life Sciences groups in Pearl Cohen’s New York office. Formerly a partner at Hogan Lovells, Veronica concentrates her practice on patent litigation and counseling. She is a registered patent attorney with extensive trial experience. Her 18 years of litigation experience includes multiple Hatch-Waxman pharmaceutical cases. Other patent infringement cases she has handled involved a wide range of technologies including: biologics, si. RNA, gene sequencing, transgenic plants, cardiovascular stents, medical devices, and drug delivery technology. Before attending law school, Veronica was a biochemist and did post-graduate research in endocrinology. She also worked in leukemia research at the John Radcliffe, Oxford, UK. And later became a research scientist at Celltech, Ltd. , UK, where she helped develop some of the first diagnostic uses for monoclonal antibodies. Representative experience • Represented Alcon in multiple Hatch-Waxman infringement cases, all of which were resolved • • • successfully by obtaining a favorable settlement on the eve of trial or by summary judgment. Successfully, defended an appeal to the Federal Circuit on an issue of first impression and subsequently defeated the petition for certiorari to the US Supreme Court Represented Alere in a patent infringement litigation involving a consumer immunohistochemical pregnancy test device implementing source code for a patented algorithm. Obtained a preliminary injunction for a biotechnology company in a trade secret case involving si. RNA lysosomal delivery technology. The case was subsequently resolved by favorable settlement Represented Ortho against Amgen in an arbitration involving rights to ARANESP®, a hematopoeitic biologic with a $3 billion market. Represented Dow Agro Sciences, in multiple biotechnology patent infringement suits. Successfully tried a 146 Action involving priority of invention of a commercially valuable gene against Monsanto in a bench trial. Invalidated Syngenta’s patents in a jury trial. Other cases were resolved by favorable settlement. Represented Cordis enforcing pioneering patents on cardiovascular stent devices , obtained verdicts of infringement in successive jury trials against multiple defendants and obtaining multimillion dollar damages awards against each defendant. Contact information (646) 878 -0881 vmunoz@pearlcohen. com Admitted • U. S. Supreme Court • U. S. Court of Appeals Fed. Circuit • U. S. District Court S. D. N. Y. • U. S. District Court, D. Conn. • State Courts of New York • State Courts of Connecticut • U. S. Patent & Trademark Office Practice areas • Intellectual Property Litigation • Patents • Trademarks • Copyright • Trade Secrets Industries • Life Sciences & Pharmaceuticals • Medical Technologies & Devices Education • The Pace University School of Law, JD, magna cum laude, 1996 • The Queen’s University of Belfast, B. Sc. , honors, Biochemistry, 1979